<SEC-DOCUMENT>0001179110-17-006134-index.html : 20170420
<SEC-HEADER>0001179110-17-006134.hdr.sgml : 20170420
<ACCEPTANCE-DATETIME>20170420202917
ACCESSION NUMBER:		0001179110-17-006134
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170418
FILED AS OF DATE:		20170420
DATE AS OF CHANGE:		20170420

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			HBM Healthcare Investments (Cayman) Ltd.
		CENTRAL INDEX KEY:			0001232258
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		17774003

	BUSINESS ADDRESS:	
		STREET 1:		2454 WEST BAY ROAD, 3RD FLOOR
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			00000
		BUSINESS PHONE:		1 345 946 8002

	MAIL ADDRESS:	
		STREET 1:		P.O BOX 30852
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1204

	FORMER NAME:	
		FORMER CONFORMED NAME:	HBM BIOVENTURES CAYMAN LTD
		DATE OF NAME CHANGE:	20030512
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 4 -
<TEXT>
Document 1 - file: edgar.html

Document 1 - RAW XML: edgar.xml

</DOCUMENT>
</SEC-DOCUMENT>